Metrics to compare | 000915 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000915PeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.6x | 18.3x | −0.4x | |
PEG Ratio | −0.99 | 0.85 | 0.00 | |
Price / Book | 2.0x | 2.3x | 2.6x | |
Price / LTM Sales | 2.9x | 3.4x | 3.0x | |
Upside (Analyst Target) | - | 46.0% | 51.9% | |
Fair Value Upside | Unlock | 16.3% | 9.4% | Unlock |
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, glycyrrhizin zinc granules, compound calcium carbonate, vitamin AD drops, iprastat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salts, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and dimercaptosuccinic acid capsules. In addition, it offers information products, such as DLP splicing display units, LCD splicing display units, image stitching processors, communication products, and industrial automation control products; and crystal products. The company is also involved in research, development, production, and sales of children's medicines and health products, as well as leasing and property management services. Shandong Wit Dyne Health Co.,Ltd. was founded in 1993 and is based in Jinan, China.